01875oam 2200505 450 991070689020332120180316110332.0(CKB)5470000002458562(OCoLC)852784168(OCoLC)654299303(OCoLC)777353954(OCoLC)1028572795(OCoLC)1028649918(EXLCZ)99547000000245856220130713d2002 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierExamining issues related to competition in the pharmaceutical marketplace a review of the FTC report, generic drug entry prior to patent expiration : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, June 13 and October 10, 2002Washington, DC :U.S.Government Printing Office,2002.1 online resource (iii, 142 pages)"Serial No. 107-140."Includes bibliographical references.Examining issues related to competition in the pharmaceutical marketplace Generic drugsDrugsPricesUnited StatesCompetitionPharmaceutical industryLegislative hearings.lcgftGeneric drugs.DrugsPricesCompetition.Pharmaceutical industry.Muris Timothy J1351335OCLCEOCLCEOCLCOOCLCQOCLCAGPOOCLCFMERUCGPOBOOK9910706890203321Examining issues related to competition in the pharmaceutical marketplace3516799UNINA